EGG-NEWS is indebted to Dr. Katelyn Jetelina and Dr. Caitlin Rivers for their summary indicating the effects of terminating the National Emergency Declaration on COVID-19. These include:-
- Home-administered antigen detection kits will continue to be available, but supply will be reduced and reimbursement by health insurance will vary.
- Bivalent and possibly multivalent boosters will continue to be available, covered by private insurance or Medicaid/Medicare for those with health insurance. This leaves approximately ten percent of our population vulnerable. Recipients of previous COVID vaccines should continue to receive boosters.
- Paxlovid antiviral will be available through 2023 but subsequently supply will depend on demand with pricing variable according to insurance program. Mutation in the SARS-CoV-2 virus may result in Paxlovid becoming ineffective.
- Monoclonal antibodies will become less effective and will probably not be available in late 2023, impacting the immunosuppressed who will lack this therapy.
- Surveillance of COVID infections will be limited. Wastewater detection will continue and hospitalization data will be available. The Centers for Disease Control and Prevention will be unable to monitor regional infection rates that are required to provide advice on prevention.
Drs. Rivers and Jetelina are justifiably concerned over the segment of our population without medical insurance, representing the most vulnerable in our population who will be deprived of vaccination, therapy and medical services.